Our pharmaceutical product line is supported by strict control processes and international standards, ensuring efficacy, safety, and quality in every solution.
Cabazither
- Active ingredient: Cabazitaxel.
- Therapeutic area: Oncology.
- Dosage form: Concentrate for solution for infusion.
- Strength: 60 mg.
- Presentation: Box x 01 vial.
- Health registration no.: EE15394
Vorzemib
- Active ingredient: Bortezomib.
- Therapeutic area: Oncology.
- Dosage form: Powder for solution for injection.
- Strength: 3.50 mg.
- Presentation: Box x 01 vial.
- Health registration no.: EE15550
Oncotaxel Plus
- Active ingredient: Docetaxel 80 mg.
- Therapeutic area: Oncology.
- Dosage form: Concentrate for solution for infusion.
- Strength: Docetaxel 80 mg / 4 ml.
- Presentation: Box x 01 vial.
- Health registration no.: EE15496
Dasataxel
- Active ingredient: Paclitaxel.
- Therapeutic area: Oncology.
- Dosage form: Concentrate for solution for infusion.
- Strength: 30 mg.
- Presentation: Box x 01 vial.
- Health registration no.: EE15485
Dasataxel
- Active ingredient: Paclitaxel.
- Therapeutic area: Oncology.
- Dosage form: Concentrate for solution for infusion.
- Strength: 300 mg.
- Presentation: Box x 01 vial.
- Health registration no.: EE15549
Colotecan
- Active ingredient: Irinotecan.
- Therapeutic area: Oncology.
- Dosage form: Concentrate for solution for infusion.
- Strength: 100 mg.
- Presentation: Box x 01 vial.
- Health registration no.: EE15487
Trexmer 500 mg
- Active ingredient: Pemetrexed.
- Therapeutic area: Oncology.
- Dosage form: Powder for concentrate for solution for infusion.
- Strength: 500 mg.
- Presentation: Box x 01 vial.
- Health registration no.: EE15417
Revirada
- Active ingredient: Sugammadex.
- Therapeutic area: Hospital.
- Dosage form: Injectable solution.
- Strength: 200 mg.
- Presentation: box x 01 vial.
- Health registration no.: EE15524
Jr. Francisco de Zela 2665, Lince, Lima. Perú.
